Opinion

Video

Tailored Therapy: Decision Making for Ovarian Cancer Treatment

A medical expert discusses treatment decision-making and modalities for ovarian cancer, including palliative care and hospice.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Dr Elise Tremblay
Related Content
Genetic factors may increase the risk of developing dilated cardiomyopathy in addition to covariates like age and sex. | Image Credit: AdobeStock_jaojormami.jpeg
August 14th 2025

Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation

Sabrina McCrear
managed care cast logo
August 14th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
Hospital exterior | Image Credit: Spiroview Inc. - stock.adobe.com
August 14th 2025

Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer

Brooke McCormick
managed care cast logo
August 14th 2025

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
Biosimilars. | Image Credit: Shutter2U - stock.adobe.com
August 14th 2025

Switching Biologics in Psoriasis Boosts Effectiveness but Raises Infection Risk

Pearl Steinzor
Blast cells AML | image credit: Nun22 - stock.adobe.com
August 14th 2025

Long-Term Follow-Up Affirms Ivosidenib's Sustained Benefit in IDH1-Mutated AML

Sabrina Serani

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo